Adaptive Implementation and Validation of the Meeting Centres Support Programme for people with dementia and their carers in Europe

MEETINGDEM旨在实施和评估一种创新和包容性的方法，以支持轻度至中度痴呆症社区居民及其家庭护理人员，称为会议中心支持计划（MCSP），在三个欧盟国家：意大利，波兰和英国。这种以证据为基础、以人为本的方法得到了积极评价，并在荷兰的90个会议中心得到了实施，现在可以在其他欧盟国家进行试验和实施。证明的好处包括高水平的用户满意度，减少行为和情绪问题，延迟住院护理，降低护理相关压力水平，提高护理人员能力，以及改善护理和福利组织之间的合作。这三个国家的项目合作伙伴将利用荷兰开发的战略和工具，并使其适应各国的具体要求，在每个国家建立一个适当的组织合作者小组，制定实施计划和工具包，实施MCSP，并在对照试验中评估该计划对痴呆症患者和护理人员的行为、情绪和生活质量的影响。其成本效益是由于使用其他（更昂贵）服务，如医院和住院护理以及精神药物的情况发生了变化。全面评估将汇集三个实施国的调查结果，以制定在整个欧盟和其他地区成功实施MCSP的建议。该项目将在36个月的时间内进行。在第一阶段（M1-18），活动将侧重于在每个国家建立一个由相关组织和用户代表组成的倡议小组，探索实现关怀的途径、潜在的促进因素和实施方案的障碍，以及制定针对国家和具体情况的实施计划和材料。在第二阶段（M19-36），将向各组织和工作人员提供培训，之后将建立会议中心并评价其影响、成本效益、用户满意度和执行过程

MEETINGDEM aims to implement and evaluate an innovative and inclusive approach to supportingcommunity dwelling people with mild to moderately severe dementia and their family carers, called theMeeting Centres Support Programme (MCSP), in three EU countries: Italy, Poland and United Kingdom.This evidence-based, person-centred, approach has been positively evaluated, and implementedin 90 meeting centers in the Netherlands, and is now well-placed to be trialled and implemented inother EU countries. Demonstrated benefits include high levels of user satisfaction, reduced behaviouraland mood problems, delayed admission to residential care, lower levels of caregiving-relatedstress, higher carer competence, and improved collaboration between care and welfare organizations.Project partners in the three countries will utilise strategies and tools developed in the Netherlandsand adapt them to country-specific requirements, establish a group of appropriate organizationalcollaborators in each country, develop an implementation plan and toolkit, implement MCSP, and evaluatethe programme in a controlled trial in terms of its impact on the behaviour, mood and quality oflife of people with dementia and carers, its cost effectiveness as a result of changes in use of other(more expensive) services, such as hospitals and residential care, and psychotropic medications. Anoverall evaluation will draw together findings from the three implementation countries to developrecommendations for successful implementation of the MCSP across the EU and beyond.The project will be carried out over a 36 month period. In Phase One (M1-18) activities will focus onestablishing an initiative group of relevant organizations and user representatives in each country,exploring pathways to care and potential facilitators and barriers to implementing the programme, anddeveloping country and context-specific implementation plans and materials. In Phase Two (M19-36)training will be provided to organizations and staff, after which the meeting centres will be establishedand evaluated for impact, cost-effectiveness, user satisfaction and implementation process